United States v. Alexis Carrazana

362 F. App'x 973
CourtCourt of Appeals for the Eleventh Circuit
DecidedJanuary 27, 2010
Docket09-13124
StatusUnpublished
Cited by1 cases

This text of 362 F. App'x 973 (United States v. Alexis Carrazana) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Alexis Carrazana, 362 F. App'x 973 (11th Cir. 2010).

Opinion

PER CURIAM:

Alexis Carrazana appeals his 72-month sentence for conspiracy to commit health care fraud. He argues that the district court erred in (1) calculating the loss amount for which he was responsible, (2) applying a two-level enhancement based on its finding that the offense involved the use of “sophisticated means,” (3) failing to grant a minor role reduction, (4) imposing *975 a procedurally and substantively unreasonable sentence, and (5) enhancing his sentence based on facts that were not admitted or found by a jury beyond a reasonable doubt. For the reasons set forth below, we affirm.

I.

Carrazana, a former medical assistant for Midway Medical, Inc. (“Midway”), was charged with conspiracy to commit health care fraud, in violation of 18 U.S.C. §§ 1347 and 1349. The indictment alleged that owners, doctors, and employees of Midway, a medical clinic that provided injection and infusion treatments to patients with human immunodeficiency virus (“HIV”), conspired to submit fraudulent Medicare claims. It charged that Carraza-na administered medically unnecessary injection and infusion treatments and fabricated and signed medical records to reflect that Midway patients had received injections or infusions when, in fact, they had not. The indictment also alleged that chemists artificially manipulated patient blood samples so that subsequent lab testing would make it appear that injections and infusion treatments billed by Midway were medically necessary.

Carrazana pled guilty. At the change-of-plea hearing, Carrazana admitted that he altered medical records, knew that his co-conspirators billed Medicare for medically unnecessary procedures and procedures that were never provided, and knew that chemists manipulated blood samples taken from Midway patients.

The presentence investigation report (“PSI”) stated that Carrazana worked at Midway from September 2002 until March 2004 and was responsible for an intended loss of $8,469,920. The PSI set Carraza-na’s base offense level at 6, pursuant to U.S.S.G. § 2Bl.l(a)(2). Carrazana’s offense level was increased by 20 levels, pursuant to § 2Bl.l(b)(l)(K), because the offense involved a loss of more than $7,000,000, but not more than $20,000,000. Carrazana also received a two-level enhancement under § 2Bl.l(b)(9)(C), because the offense involved sophisticated means; a two-level enhancement under § 2Bl.l(b)(13)(A), because the offense “involved the conscious reckless risk of death or bodily injury;” and a two-level enhancement under § 3B1.3, for use of a special skill in connection with the offense. Car-razana received a three-level reduction, pursuant to §§ 3El.l(a), (b), for acceptance of responsibility, resulting in a total offense level of 29. Carrazana’s offense level of 29 combined with criminal history category I to yield a guideline imprisonment range of 87 to 108 months.

Carrazana filed objections to the PSI, arguing that (1) his intended loss should be calculated as less than $7,000,000, because he effectively withdrew from the conspiracy by terminating his employment with Midway in March 2004; (2) he should have received a minor role reduction; (3) the conspiracy did not involve sophisticated means; (4) and the offense did not involve the conscious or reckless risk of death or serious bodily injury. Carrazana also pointed to several factors that he argued supported a sentence below the guideline range.

At the sentencing hearing, the court sustained Carrazana’s objection to the § 2Bl.l(b)(13)(A) enhancement for conscious or reckless disregard of the risk of death or serious injury. It noted, however, that it would consider that the conspiracy involved administering unnecessary medication, when considering the factors under 18 U.S.C. § 3553(a). The court then determined that Carrazana was subject to a total offense level of 27, criminal history category I, and a guideline imprisonment range of 70' to 87 months. The court overruled Carrazana’s objection to *976 the fraud-loss amount, determining that Carrazana did not effectively withdraw from the conspiracy by merely quitting his job in March 2004, because withdrawal from a conspiracy requires “more than just terminating one’s act of participation in the conspiracy.” The court also declined to grant Carrazana a minor role reduction, finding that, although Carrazana was less culpable than some of his co-conspirators, he still played “an integral role” in the offense. The court denied Carrazana’s objection to the two-level sophisticated means enhancement, stating that “certainly the conspiracy clearly qualifies.” It also denied Carrazana’s request for a below-range sentence, noting that Carrazana’s actions “show[ed] a total disregard for everyone else other than [himself].” The court pointed out that Carrazana made a conscious decision every day that he went to work to inject patients with unnecessary medication and noted that Carrazana “obviously wanted to harm society because of his activities over a year and a half where he stole money from a very important Medicare program.” The court sentenced Carrazana to 72 months’ imprisonment, followed by 3 years of supervised release. It also ordered Carrazana to pay $3,687,893 in restitution.

II.

Loss Amount

We review “the district court’s loss determination for clear error.” United States v. Woodard, 459 F.3d 1078, 1087 (11th Cir.2006). The applicable guideline provision provides for an 18-level increase in a defendant’s base offense level if the offense involved a loss of more than $2,500,000 and an increase of 20 levels if the offense resulted in a loss of more than $7,000,000. U.S.S.G. § 2Bl.l(b)(l). The commentary provides that the proper loss amount for purposes of calculating the enhancement is “the greater of actual loss or intended loss.” U.S.S.G. § 2B1.1, comment. (n.3(A)).

“[T]he district court may hold all participants in a conspiracy responsible for the losses resulting from the reasonably foreseeable acts of co-conspirators in furtherance of the conspiracy.” United States v. Dabbs, 134 F.3d 1071, 1082 (11th Cir.1998). If a defendant withdraws from a conspiracy, he is not responsible at sentencing for actions taken by co-conspirators after his withdrawal. Id. at 1083. In order to prove withdrawal from a conspiracy, the defendant must show “(1) that he has taken affirmative steps, inconsistent with the objectives of the conspiracy, to disavow or to defeat the objectives of the conspiracy; and (2) that he made a reasonable effort to communicate those acts to his co-conspirators or that he disclosed the scheme to law enforcement authorities.” United States v. Starrett, 55 F.3d 1525, 1550 (11th Cir. 1995). “A mere cessation of participation in the conspiracy is insufficient to prove withdrawal.” Dabbs, 134 F.3d at 1083; see United States v. Young,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nelson v. United States
M.D. Florida, 2021

Cite This Page — Counsel Stack

Bluebook (online)
362 F. App'x 973, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-alexis-carrazana-ca11-2010.